                         SEQUENCE LISTING

<110>  GlaxoSmithKline Biologicals SA
       Vande Velde, Vincent
 
<120>  CALCIUM FLUORIDE COMPOSITIONS

<130>  VR65583Wo

<150>  GB1318862.8
<151>  2013-10-25

<150>  US 61/946040
<151>  2014-02-28

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic immunostimulatory oligonucleotide

<400>  1
tccatgacgt tcctgacgtt                                                   20


<210>  2
<211>  18
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic immunostimulatory oligonucleotide

<400>  2
tctcccagcg tgcgccat                                                     18


<210>  3
<211>  30
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic immunostimulatory oligonucleotide

<400>  3
accgatgacg tcgccggtga cggcaccacg                                        30


<210>  4
<211>  24
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic immunostimulatory oligonucleotide

<400>  4
tcgtcgtttt gtcgttttgt cgtt                                              24


<210>  5
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic immunostimulatory oligonucleotide

<400>  5
tccatgacgt tcctgatgct                                                   20


<210>  6
<211>  22
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic immunostimulatory oligonucleotide

<400>  6
tcgacgtttt cggcgcgcgc cg                                                22


